Clinical Trial Update: An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of the hydromorphone oral osmotic system (OROS) for cancer pain in Korean participants has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• Hydromorphone (OROS) (hydromorphone)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Cancer Pain | Phase 4 | Status: COMPLETED | Results posted: 2013-08-26